By Mohanad Alfahad ( PhD student in the Keele Nanopharmaceutics Research Group , Institute for Science & Technology in Medicine , Keele University )
Nanopharmaceutics Symposium
Successful second annual event at Keele University
The second annual Keele Nanopharmaceutics Symposium took place in the Sustainability Hub at Keele University on 15th July 2016 . The symposium , organised by the Keele Nanopharmaceutics group , hosted researchers from other universities and industry from across the UK with common interests in nanodrug formulation . Topics discussed included the use of nanotechnology for the delivery of specific fragments of small interfering RNA , proteins and drugs as well as particulates with multiple uses in both diagnosis and therapy . Guests from across the UK , ranging from PhD students to Professors shared their research findings through a series of invited talks and posters . Speakers included Dr Dimitrios Lamprou from the University of Strathclyde , Professor Afzal Mohammed from Aston University , Dr Yimin Chao from University of East Anglia , Dr Annalisa Tirella from University of Manchester , Dr ’ s Clare Hoskins and Neil Telling from Keele University along with others . The event was set up with the aim of providing a forum to promote networking between the scientific community and provide a suitable environment to foster new collaborations .
“
The event was set up with the aim of providing a forum to promote networking between the scientific community and provide a suitable environment to foster new collaborations .
The event was supported by the Royal Society of Chemistry : Chemical Nanosciences and Nanotechnology Network and the British Society of Nanomedicine - two of the key bodies in the UK for such work and their ongoing support has been greatly appreciated by the Keele Nanotherapeutics group . The symposium was well attended and received excellent reviews with firm commitment from key groups for future attendance . The attending delegates included those from University of Liverpool , University of Birmingham , University of Wolverhampton , Lucideon , Sanofi and many more institutions including strong support from Keele University . The hope now is to grow this event annually and to promote , not only the work carried out in the Keele Nanopharmaceutics group , but also the research strengths , which align to this from across the Faculty of Medicine and Health Sciences at Keele University . The organisation of next years ’ event has already begun .
If you would like more information about speaker opportunities or attendance at next year ’ s symposium please contact Dr Clare Hoskins ( c . hoskins @ keele . ac . uk ).
TRANSLATE 7